Related Experiment Video
Updated: Aug 1, 2026
09:31
Automated Quantification of Hematopoietic Cell – Stromal Cell Interactions in Histological Images of Undecalcified Bone
Published on: April 8, 2015
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
American Journal of Hematology
|September 1, 1983
Summary
This study details unique red blood cell changes in drug-induced oxidant hemolysis, differentiating it from other hemolytic anemias. Recognizing these specific "bite cells" aids in diagnosing and treating this condition.
Area of Science:
- Hematology
- Pathology
Background:
- Investigating drug-induced oxidant hemolysis, a condition distinct from glucose-6-phosphate dehydrogenase (G6PD) deficiency or unstable hemoglobinopathy.
- Examining five patients with no prior history of hemolytic disease, presenting with drug-induced oxidant hemolysis.
Observation:
- Utilizing light and scanning electron microscopy to study blood morphology in affected patients.
- Comparing observed red blood cell deformities with those seen in microangiopathic hemolytic anemia (MAHA) and G6PD deficiency.
Findings:
- Patients exhibited extremely common 'bite cells,' a morphology rarely seen in MAHA or G6PD deficiency.
- Distinctly, cell fragments (common in MAHA) and eccentrocytes (common in G6PD deficiency) were seldom observed.
Implications:
- The unique morphologic profile, particularly the prevalence of bite cells, can help differentiate drug-induced oxidant hemolysis.
- Accurate identification of specific red blood cell abnormalities facilitates timely and appropriate therapeutic interventions for hemolytic processes.
